[Olemorphocycline treatment of calculous and noncalculous pyelonephritis].
40 patients suffering from calculous and non-calculous pyelonephrits were treated with olemorphocycline administered intravenously in a dose of 250 00 Units 2 times a day for 5--7 days. The clinical effect was observed in 62.5 per cent of the cases. In 54.7 per cent of the cases the isolates were resistant to oleandomycin and morphocycline. The kidney tissue and urine from the kidney pelvis taken during surgical operations of 20 patients were plated out. Staphylocci were most often detected in the platings of the kidney tissue. The microflora of the urinary bladder before the treatment and that of the urine from the kidney pelvis and the kidney tissue taken during the surgical operation was mainly ident
D000293:Adolescent; D000328:Adult; D000368:Aged; D001702:Biopharmaceutics; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009827:Oleandomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000188:drug therapy* / Q000382:microbiology; D013754:Tetracyclines / Q000008:administration & dosage / Q000627:therapeutic use*; D014556:Urine / Q000382:microbiology
D004338:Drug Combinations; D013754:Tetracyclines; D009827:Oleandomycin
Lechenie olemorfotsiklinom bol'nykh kal'kuleznym i nekal'kuleznym pielonefritom